Loading…
Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma
Purpose Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The p...
Saved in:
Published in: | International journal of colorectal disease 2009-11, Vol.24 (11), p.1287-1296 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3 |
container_end_page | 1296 |
container_issue | 11 |
container_start_page | 1287 |
container_title | International journal of colorectal disease |
container_volume | 24 |
creator | Schmitz, Klaus Jürgen Müller, Carmen Ina Reis, Henning Alakus, Hakan Winde, Günther Baba, Hideo Andreas Wohlschlaeger, Jeremias Jasani, Bharat Fandrey, Joachim Schmid, Kurt Werner |
description | Purpose
Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The present study aimed to analyse the prognostic impact of HIF-1α and MT expression in colorectal cancer and to evaluate a possible link of combined HIF-1α and MT expression with colorectal cancer progression.
Materials and methods
We investigated the relationship of HIF-1α and MT with each other and clinicopathological parameters including proliferative activity (Ki67) and apoptosis (terminal desoxyribonucleotide transferase-mediated dUTP nick-end labelling) using immunohistochemistry.
Results
HIF-1α expression was identified as an independent prognostic parameter in multivariate survival analysis and characterised an aggressive cancer phenotype. In addition, HIF-1α was significantly linked to an increased expression of MT.
Conclusions
HIF-1α expression qualified as an independent prognostic and characterised an aggressive cancer phenotype associated with an increased expression of MT. Our study suggests that MT can be added to the complex biological pathways induced by hypoxia in human cancer tissue. |
doi_str_mv | 10.1007/s00384-009-0753-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734077130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734077130</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3</originalsourceid><addsrcrecordid>eNp1kU-LFDEQxYMo7uzqB_AiQZA9tVaS7k7nKIP_YMGLnkN1unomS7ozJt2yc_Sbm2EGFwRPoap-71WRx9grAe8EgH6fAVRXVwCmAt2oqnvCNqJWshKylU_ZBoQ2lTBNd8Wuc76HUre6fs6uSk8aU-sN-72NU-9nGjjOGI7ZZx5Hvj8e4oPHys_D6nwfiI_olpi44BgOeyzwwCdaMIS47H2cyc-8wN7hQrlMOe52iXL2v4jntV-OBzr5uhhiIld03GFyfo4TvmDPRgyZXl7eG_bj08fv2y_V3bfPX7cf7ipXt-1SScBaG2eAmqbrh96Q6M0gR0Ale0U4aGVKLTvTAYLqR10LxK70RtW5mtQNuz37HlL8uVJe7OSzoxBwprhmq1UNWgsFhXzzD3kf11S-J1sp2ga0grZA4gy5FHNONNpD8hOmoxVgT-nYczq2pGNP6diuaF5fjNd-ouFRcYmjAG8vAGaHYUw4O5__clKCMEqclsszl8to3lF6vPD_2_8AlEmpGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216507306</pqid></control><display><type>article</type><title>Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma</title><source>Springer Nature</source><creator>Schmitz, Klaus Jürgen ; Müller, Carmen Ina ; Reis, Henning ; Alakus, Hakan ; Winde, Günther ; Baba, Hideo Andreas ; Wohlschlaeger, Jeremias ; Jasani, Bharat ; Fandrey, Joachim ; Schmid, Kurt Werner</creator><creatorcontrib>Schmitz, Klaus Jürgen ; Müller, Carmen Ina ; Reis, Henning ; Alakus, Hakan ; Winde, Günther ; Baba, Hideo Andreas ; Wohlschlaeger, Jeremias ; Jasani, Bharat ; Fandrey, Joachim ; Schmid, Kurt Werner</creatorcontrib><description>Purpose
Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The present study aimed to analyse the prognostic impact of HIF-1α and MT expression in colorectal cancer and to evaluate a possible link of combined HIF-1α and MT expression with colorectal cancer progression.
Materials and methods
We investigated the relationship of HIF-1α and MT with each other and clinicopathological parameters including proliferative activity (Ki67) and apoptosis (terminal desoxyribonucleotide transferase-mediated dUTP nick-end labelling) using immunohistochemistry.
Results
HIF-1α expression was identified as an independent prognostic parameter in multivariate survival analysis and characterised an aggressive cancer phenotype. In addition, HIF-1α was significantly linked to an increased expression of MT.
Conclusions
HIF-1α expression qualified as an independent prognostic and characterised an aggressive cancer phenotype associated with an increased expression of MT. Our study suggests that MT can be added to the complex biological pathways induced by hypoxia in human cancer tissue.</description><identifier>ISSN: 0179-1958</identifier><identifier>EISSN: 1432-1262</identifier><identifier>DOI: 10.1007/s00384-009-0753-8</identifier><identifier>PMID: 19529947</identifier><identifier>CODEN: IJCDE6</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Amino Acids, Dicarboxylic - pharmacology ; Apoptosis - drug effects ; Biological and medical sciences ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - pathology ; Epithelial Cells - drug effects ; Epithelial Cells - metabolism ; Epithelial Cells - pathology ; Female ; Gastroenterology ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatology ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; Immunohistochemistry ; Internal Medicine ; Kaplan-Meier Estimate ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Metallothionein - metabolism ; Original Article ; Phenotype ; Proctology ; Reactive Oxygen Species - metabolism ; Staining and Labeling ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Surgery ; Tumors</subject><ispartof>International journal of colorectal disease, 2009-11, Vol.24 (11), p.1287-1296</ispartof><rights>Springer-Verlag 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3</citedby><cites>FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22019316$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19529947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmitz, Klaus Jürgen</creatorcontrib><creatorcontrib>Müller, Carmen Ina</creatorcontrib><creatorcontrib>Reis, Henning</creatorcontrib><creatorcontrib>Alakus, Hakan</creatorcontrib><creatorcontrib>Winde, Günther</creatorcontrib><creatorcontrib>Baba, Hideo Andreas</creatorcontrib><creatorcontrib>Wohlschlaeger, Jeremias</creatorcontrib><creatorcontrib>Jasani, Bharat</creatorcontrib><creatorcontrib>Fandrey, Joachim</creatorcontrib><creatorcontrib>Schmid, Kurt Werner</creatorcontrib><title>Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma</title><title>International journal of colorectal disease</title><addtitle>Int J Colorectal Dis</addtitle><addtitle>Int J Colorectal Dis</addtitle><description>Purpose
Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The present study aimed to analyse the prognostic impact of HIF-1α and MT expression in colorectal cancer and to evaluate a possible link of combined HIF-1α and MT expression with colorectal cancer progression.
Materials and methods
We investigated the relationship of HIF-1α and MT with each other and clinicopathological parameters including proliferative activity (Ki67) and apoptosis (terminal desoxyribonucleotide transferase-mediated dUTP nick-end labelling) using immunohistochemistry.
Results
HIF-1α expression was identified as an independent prognostic parameter in multivariate survival analysis and characterised an aggressive cancer phenotype. In addition, HIF-1α was significantly linked to an increased expression of MT.
Conclusions
HIF-1α expression qualified as an independent prognostic and characterised an aggressive cancer phenotype associated with an increased expression of MT. Our study suggests that MT can be added to the complex biological pathways induced by hypoxia in human cancer tissue.</description><subject>Amino Acids, Dicarboxylic - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Epithelial Cells - drug effects</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - pathology</subject><subject>Female</subject><subject>Gastroenterology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>Immunohistochemistry</subject><subject>Internal Medicine</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metallothionein - metabolism</subject><subject>Original Article</subject><subject>Phenotype</subject><subject>Proctology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Staining and Labeling</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Surgery</subject><subject>Tumors</subject><issn>0179-1958</issn><issn>1432-1262</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kU-LFDEQxYMo7uzqB_AiQZA9tVaS7k7nKIP_YMGLnkN1unomS7ozJt2yc_Sbm2EGFwRPoap-71WRx9grAe8EgH6fAVRXVwCmAt2oqnvCNqJWshKylU_ZBoQ2lTBNd8Wuc76HUre6fs6uSk8aU-sN-72NU-9nGjjOGI7ZZx5Hvj8e4oPHys_D6nwfiI_olpi44BgOeyzwwCdaMIS47H2cyc-8wN7hQrlMOe52iXL2v4jntV-OBzr5uhhiIld03GFyfo4TvmDPRgyZXl7eG_bj08fv2y_V3bfPX7cf7ipXt-1SScBaG2eAmqbrh96Q6M0gR0Ale0U4aGVKLTvTAYLqR10LxK70RtW5mtQNuz37HlL8uVJe7OSzoxBwprhmq1UNWgsFhXzzD3kf11S-J1sp2ga0grZA4gy5FHNONNpD8hOmoxVgT-nYczq2pGNP6diuaF5fjNd-ouFRcYmjAG8vAGaHYUw4O5__clKCMEqclsszl8to3lF6vPD_2_8AlEmpGQ</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Schmitz, Klaus Jürgen</creator><creator>Müller, Carmen Ina</creator><creator>Reis, Henning</creator><creator>Alakus, Hakan</creator><creator>Winde, Günther</creator><creator>Baba, Hideo Andreas</creator><creator>Wohlschlaeger, Jeremias</creator><creator>Jasani, Bharat</creator><creator>Fandrey, Joachim</creator><creator>Schmid, Kurt Werner</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20091101</creationdate><title>Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma</title><author>Schmitz, Klaus Jürgen ; Müller, Carmen Ina ; Reis, Henning ; Alakus, Hakan ; Winde, Günther ; Baba, Hideo Andreas ; Wohlschlaeger, Jeremias ; Jasani, Bharat ; Fandrey, Joachim ; Schmid, Kurt Werner</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Amino Acids, Dicarboxylic - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Epithelial Cells - drug effects</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - pathology</topic><topic>Female</topic><topic>Gastroenterology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>Immunohistochemistry</topic><topic>Internal Medicine</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metallothionein - metabolism</topic><topic>Original Article</topic><topic>Phenotype</topic><topic>Proctology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Staining and Labeling</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmitz, Klaus Jürgen</creatorcontrib><creatorcontrib>Müller, Carmen Ina</creatorcontrib><creatorcontrib>Reis, Henning</creatorcontrib><creatorcontrib>Alakus, Hakan</creatorcontrib><creatorcontrib>Winde, Günther</creatorcontrib><creatorcontrib>Baba, Hideo Andreas</creatorcontrib><creatorcontrib>Wohlschlaeger, Jeremias</creatorcontrib><creatorcontrib>Jasani, Bharat</creatorcontrib><creatorcontrib>Fandrey, Joachim</creatorcontrib><creatorcontrib>Schmid, Kurt Werner</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of colorectal disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmitz, Klaus Jürgen</au><au>Müller, Carmen Ina</au><au>Reis, Henning</au><au>Alakus, Hakan</au><au>Winde, Günther</au><au>Baba, Hideo Andreas</au><au>Wohlschlaeger, Jeremias</au><au>Jasani, Bharat</au><au>Fandrey, Joachim</au><au>Schmid, Kurt Werner</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma</atitle><jtitle>International journal of colorectal disease</jtitle><stitle>Int J Colorectal Dis</stitle><addtitle>Int J Colorectal Dis</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>24</volume><issue>11</issue><spage>1287</spage><epage>1296</epage><pages>1287-1296</pages><issn>0179-1958</issn><eissn>1432-1262</eissn><coden>IJCDE6</coden><abstract>Purpose
Hypoxia-inducible factor 1 (HIF-1) is a hypoxia-induced transcription factor that regulates gene expression in critical pathways involved in tumour growth and metastasis. Metallothionein (MT) is a group of small molecular weight cysteine-rich proteins with a broad variety of functions. The present study aimed to analyse the prognostic impact of HIF-1α and MT expression in colorectal cancer and to evaluate a possible link of combined HIF-1α and MT expression with colorectal cancer progression.
Materials and methods
We investigated the relationship of HIF-1α and MT with each other and clinicopathological parameters including proliferative activity (Ki67) and apoptosis (terminal desoxyribonucleotide transferase-mediated dUTP nick-end labelling) using immunohistochemistry.
Results
HIF-1α expression was identified as an independent prognostic parameter in multivariate survival analysis and characterised an aggressive cancer phenotype. In addition, HIF-1α was significantly linked to an increased expression of MT.
Conclusions
HIF-1α expression qualified as an independent prognostic and characterised an aggressive cancer phenotype associated with an increased expression of MT. Our study suggests that MT can be added to the complex biological pathways induced by hypoxia in human cancer tissue.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>19529947</pmid><doi>10.1007/s00384-009-0753-8</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0179-1958 |
ispartof | International journal of colorectal disease, 2009-11, Vol.24 (11), p.1287-1296 |
issn | 0179-1958 1432-1262 |
language | eng |
recordid | cdi_proquest_miscellaneous_734077130 |
source | Springer Nature |
subjects | Amino Acids, Dicarboxylic - pharmacology Apoptosis - drug effects Biological and medical sciences Cell Line, Tumor Cell Proliferation - drug effects Colorectal Neoplasms - metabolism Colorectal Neoplasms - pathology Epithelial Cells - drug effects Epithelial Cells - metabolism Epithelial Cells - pathology Female Gastroenterology Gastroenterology. Liver. Pancreas. Abdomen Hepatology Humans Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Immunohistochemistry Internal Medicine Kaplan-Meier Estimate Male Medical sciences Medicine Medicine & Public Health Metallothionein - metabolism Original Article Phenotype Proctology Reactive Oxygen Species - metabolism Staining and Labeling Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Surgery Tumors |
title | Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20analysis%20of%20hypoxia-inducible%20factor%201%20alpha%20and%20metallothionein%20indicates%20an%20aggressive%20subtype%20of%20colorectal%20carcinoma&rft.jtitle=International%20journal%20of%20colorectal%20disease&rft.au=Schmitz,%20Klaus%20J%C3%BCrgen&rft.date=2009-11-01&rft.volume=24&rft.issue=11&rft.spage=1287&rft.epage=1296&rft.pages=1287-1296&rft.issn=0179-1958&rft.eissn=1432-1262&rft.coden=IJCDE6&rft_id=info:doi/10.1007/s00384-009-0753-8&rft_dat=%3Cproquest_cross%3E734077130%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c466t-20a479c90e558bdb9e1b9d2f0a32b3ead7399d228980a03bf741aa899df38c4e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=216507306&rft_id=info:pmid/19529947&rfr_iscdi=true |